Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Jun 17.
Published in final edited form as: Org Lett. 2016 May 27;18(12):2954–2957. doi: 10.1021/acs.orglett.6b01299

Phosphine-Catalyzed Intramolecular Cyclizations of α-Nitroethylallenoates Forming (Z)-Furanone Oximes

Qing-Fa Zhou †,, Kui Zhang , Lingchao Cai , Ohyun Kwon ‡,*
PMCID: PMC4922534  NIHMSID: NIHMS794180  PMID: 27232451

Abstract

A novel and efficient phosphine-catalyzed intramolecular cyclization of α-nitroethylallenic esters is reported. This process appears to be practical for the stereoselective syntheses of (Z)-furan-2(3H)-one oxime derivatives in excellent yields. Mechanistically, the reaction involves a phosphine-catalyzed Michael addition of an alkylideneazinate and rearrangement of the cyclic nitronate to the α-nitrosodihydrofuran.

graphic file with name nihms-794180-f0001.jpg


Nucleophilic phosphine catalysis has recently flourished because of its high versatility, operational ease, and low cost. In this context, nucleophilic phosphine-catalyzed cyclizations have become extremely multifaceted synthetic methodologies for preparing various carbocycles and heterocycles.1 Some notable examples include the intramolecular Morita–Baylis–Hillman (MBH) reaction,2 the intramolecular Rauhut–Currier reaction,3 and various annulations based on allenes,4 MBH alcohol derivatives,5 and alkynes.6 In addition to these cyclization reactions, methods have also been developed for the syntheses of oxygen-, sulfur-, and nitrogen-containing heterocycles through double-Michael, γ-umpolung–Michael, and intramolecular γ-umpolung additions of 2,3-butadienoates and 2-butynoates.7

Based on these earlier studies, we hypothesized that 2-(2′-nitroethyl)allenic esters 1 would undergo intramolecular γ-umpolung additions in the presence of phosphine catalysts to yield highly substituted cyclopentenes A (Figure 1).8a We could not, however, exclude the possibility of forming cyclic nitronates B through intramolecular Michael addition of the oxygen anion of the alkylideneazinate intermediate.8b To our surprise, compounds 1 produced, instead, five-membered cyclic N-hydroxyimidic acid esters 2 as novel products in high yields under the influence of a tertiary phosphine catalyst. Methods for the synthesis of cyclic N-hydroxyimidic acid esters are scarce, with the only known processes being oxidative ring closure of γ- or δ-hydroxyl oximes,9 rearrangement of nitronates,10 organoselenium-induced cyclization of β,γ-unsaturated hydroxamic acids,11 and tandem reactions of β-nitrostyrenes with 1,3-dicarbonyl compounds.12 Because of their potential biological activities,9b herein we report a novel approach toward five-membered cyclic N-hydroxyimidic acid esters 2 through highly effective phosphine-catalyzed cyclizations of 2-(2′-nitroethyl)allenic esters 1. This transformation, which occurs through a mechanistically intriguing cascade process, appears to be a practical and operationally simple method for preparing five-membered cyclic N-hydroxyimidic acid esters under extremely mild conditions.

Figure 1.

Figure 1

Phosphine-catalyzed intramolecular cyclizations based on γ-umpolung and Michael additions.

To prepare the requisite α-(nitroethyl)allenic esters 1 for this study, a series of phosphoranes 4 were formed through Michael additions of carbethoxymethylenetriphenylphosphorane to nitroalkenes 3 (Scheme 1). Treatment of the stabilized ylides 4 with AcCl and Et3N produced the allenoates 1 for the subsequent phosphine catalysis reactions.13

Scheme 1.

Scheme 1

Synthesis of α-(Nitroethyl)allenic Esters 1

With these α-(nitroethyl)allenic esters 1 in hand, ethyl 2-(2-nitro-1-phenylethyl)buta-2,3-dienoate (1a) was selected for the initial trial reaction with 20 mol % Ph3P as the catalyst in CH2Cl2 at room temperature (Table 1). To our delight, the cyclic N-hydroxyimidic acid ester 2a was obtained with a synthetically useful level of efficiency (entry 1). To improve the product yield, various solvents were examined (entries 2–5). MeCN proved to be the most efficient reaction medium, providing the cyclic N-hydroxyimidic acid ester 2a in 95% isolated yield after 1 h (entry 5). Subsequently, the potential of several commonly used phosphines as catalysts was probed in MeCN (entries 6–12). MePh2P at 10 mol % was the best catalyst in terms of product yield and reaction time (entry 13). Me2PhP, Me3P, and Bu3P also facilitated the cyclization of 1a, while, surprisingly, Bn3P was ineffective (entries 6–10). P(OEt)3 did not catalyze this reaction, even when performed under reflux (entries 11 and 12). Additionally, the loading of MePh2P could be lowered to 5 mol % without impacting the product yield, although a slightly longer reaction time was required (entry 14). Notably, 1 mol % of catalyst was also sufficient for this reaction, offering the product in 77% yield within 40 min under reflux (entries 15 and 16). Only a trace amount of the product formed when using 0.1 mol % of catalyst, even at elevated temperature (entries 17 and 18). Notably, the loading of phosphine catalysts in nucleophilic phosphine-catalyzed reactions is typically greater than 10 mol %, so this reaction is a rare example in which 1 mol % of a phosphine catalyst can effectively promote such a reaction. No product was obtained when the reaction was performed in the absence of a phosphine (entry 19).

Table 1.

Optimization of Reaction Conditionsa

graphic file with name nihms-794180-f0004.jpg
entry catalyst (mol%) temp solvent time yield (%)b
1 Ph3P (20) rt CH2CI2 24 h 71
2 Ph3P (20) rt THF 24 h 0
3 Ph3P (20) rt toluene 24 h trace
4 Ph3P (20) rt Et20 2h 0
5 Ph3P (20) rt MeCN 1h 95
6 MePh2P (20) rt MeCN 10min 92
7 Me2PhP (20) rt MeCN 10 min 86
8 Me3P (20) rt MeCN 6 min 81
9 Bu3P (20) rt MeCN 30 min 92
10 Bn3P (20) rt MeCN 24 h 0
11 P(OEt)3 (20) rt MeCN 24 h 0
12 P(OEt)3 (20) reflux MeCN 24 h 0
13 MePh2P (10) rt MeCN 30 min 96
14 MePh2P (5) rt MeCN 40 min 96
15 MePh2P (1) rt MeCN 24 h 84
16 MePh2P (1) reflux MeCN 40 min 77
17 MePh2P (0.1) rt MeCN 24 h trace
18 MePh2P (0.1) reflux MeCN 24 h trace
19 none rt MeCN 24 h 0
a

Reaction of 1a (0.1 mmol) was performed in the listed solvent (1 mL).

b

Isolated yield.

With the optimal conditions in hand, several 2-(2-nitro-1-arylethyl)buta-2,3-dienoate esters 1 were converted to their corresponding five-membered cyclic N-hydroxyimidic acid esters 2 (Table 2). The yields for these cycloisomerizations were generally very high. Both meta- and para-substituted phenyl moieties, possessing either electron-donating or -withdrawing substituents, were well tolerated (entries 1–12). For example, α-(2-nitro-1-arylethyl)allenic esters presenting p- and m-methoxyphenyl groups underwent their reactions smoothly, providing the desired products 2d and 2i in 97% and 93% yields, respectively (entries 4 and 9). Importantly, halogen substituents (F, Cl, Br) remained intact under the reaction conditions, providing a handle for subsequent transformations through various coupling protocols (entries 5–7 and 10–12). The yield was low when the aryl group was trisubstituted (entry 13), but it improved when using a higher catalyst loading (10 mol %; entry 14). The reaction was equally effective at producing the corresponding product in good yield when a 2-naphthyl group was present (entry 15). Gratifyingly, the benzene ring of the substrates 1 could be replaced by heteroaryl groups, providing the furyl- and thienyl-substituted five-membered cyclic N-hydroxyimidic acid esters 2o and 2p in 86% and 73% yields, respectively (entries 16 and 17). γ-Substituted allenoates did not participate in this process (entry 18), presumably because the steric bulk lowered the electro-philicity. Variation of the ester group had no obvious effect on the reaction, with the cyclized products again obtained in high yield (entries 19–21). The structures of the products were confirmed through X-ray crystallographic analysis of compound 2m (Figure 2).14

Table 2.

Synthesis of Cyclic N-Hydroxyimidic Acid Estersa

graphic file with name nihms-794180-f0005.jpg
entry R1 R2 R3 time (min) product yield (%)b
1 Ph H Et 40 2a 96
2 4-MeC6H4 H Et 20 2b 96
3 4-MeSC6H4 H Et 40 2c 94
4 4-MeOC6H4 H Et 15 2d 97
5 4-BrC6H4 H Et 30 2e 87
6 4-ClC6H4 H Et 20 2f 93
7 4-FC6H4 H Et 30 2g 94
8 4-PhC6H4 H Et 20 2h 91
9 3-MeOC6H4 H Et 40 2i 93
10 3-BrC6H4 H Et 30 2j 95
11 3-ClC6H4 H Et 30 2k 88
12 3-FC6H2 H Et 35 2l 96
13 4-(AcO)-3,5-(MeO)2C6H2 H Et 180 2m 50
14 4-(AcO)-3,5-(MeO)2C6H2 H Et 50 2m 79c
15 2-naphthyl H Et 30 2n 94
16 5-Me-2-furyl H Et 20 2o 86
17 2-thienyl H Et 40 2p 73
18d Ph Me Et 720 - -
19 Ph H Me 35 2q 93
20 Ph H Bn 40 2r 88
21 Ph H t-Bu 40 2s 92
a

All reactions were performed using a β′-nitroalkylallenic ester 1 (0.1 mmol) and MePh2P (5 mol %) in MeCN at room temperature.

b

Isolated yield.

c

10 mol % of MePh2P was used.

d

No product was formed.

Figure 2.

Figure 2

ORTEP representation of the solid state structure of 2m.

Scheme 2 presents a proposed mechanism to account for the formation of the cyclic N-hydroxyimidic acid esters 2. Conjugate addition of the phosphine to the α-(nitroethyl)-allenic ester 1 leads to the formation of the zwitterionic intermediates 5↔6. 1,5-Proton transfer of the intermediate 6 yields the α-nitro anion 7, the alternative resonance form (the alkylideneazinate 8) of which undergoes cyclization to form the nitronate 9. β-Elimination of the phosphine from the zwitterionic intermediate 9 produces the cyclic nitronate B, which rearranges to produce the 2-nitrosodihydrofuran intermediate 10,10 with tautomerization giving the five-membered cyclic N-hydroxyimidic acid ester 2.

Scheme 2.

Scheme 2

Mechanism of Phosphine-Catalyzed Formation of N-Hydroxyimidic Acid Esters 2

In conclusion, we have observed the unprecedented chemoselective phosphine-catalyzed intramolecular cyclization of α-nitroethylallenic esters to five-membered cyclic N-hydroxyimidic acid esters. This catalytic process, performed under mild and seemingly general conditions, provides access to five-membered cyclic N-hydroxyimidic acid esters in high yields. This transformation is a rare example of the rearrangement of cyclic nitronates to furanone oximes.

Supplementary Material

SI

ACKNOWLEDGMENTS

We thank the NIH (GM071779) for financial support.

Footnotes

ASSOCIATED CONTENT

Supporting Information

The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.orglett.6b01299.

Crystallographic data for compound 2m (CIF)

Experimental procedures and characterization data for the starting materials 1 and the products 2 (PDF)

The authors declare no competing financial interest.

REFERENCES

  • 1.For selected reviews, see: Lu X, Zhang C, Xu Z. Acc. Chem. Res. 2001;34:535. doi: 10.1021/ar000253x. Methot JL, Roush WR. Adv. Synth. Catal. 2004;346:1035. Nair V, Menon RS, Sreekanth AR, Abhilash N, Biju AT. Acc. Chem. Res. 2006;39:520. doi: 10.1021/ar0502026. Ye L-W, Zhou J, Tang Y. Chem. Soc. Rev. 2008;37:1140. doi: 10.1039/b717758e. Cowen BJ, Miller SJ. Chem. Soc. Rev. 2009;38:3102. doi: 10.1039/b816700c. Marinetti A, Voituriez A. Synlett. 2010;2010:174. Wei Y, Shi M. Acc. Chem. Res. 2010;43:1005. doi: 10.1021/ar900271g. Wang S-X, Han X, Zhong F, Wang Y, Lu Y. Synlett. 2011;2011:2766. Zhao Q-Y, Lian Z, Wei Y, Shi M. Chem. Commun. 2012;48:1724. doi: 10.1039/c1cc15793k. Fan YC, Kwon O. Chem. Commun. 2013;49:11588. doi: 10.1039/c3cc47368f. Wang Z, Xu X, Kwon O. Chem. Soc. Rev. 2014;43:2927. doi: 10.1039/c4cs00054d. Xiao Y, Guo H, Kwon O. Aldrichimica Acta. 2016;49:3..
  • 2.Roth F, Gygax P, Fráter G. Tetrahedron Lett. 1992;33:1045. [Google Scholar]
  • 3.a Frank SA, Mergott DJ, Roush WR. J. Am. Chem. Soc. 2002;124:2404. doi: 10.1021/ja017123j. [DOI] [PubMed] [Google Scholar]; b Wang L-C, Luis AL, Agapiou K, Jang H-Y, Krische MJ. J. Am. Chem. Soc. 2002;124:2402. doi: 10.1021/ja0121686. [DOI] [PubMed] [Google Scholar]; c Aroyan CE, Miller SJ. J. Am. Chem. Soc. 2007;129:256. doi: 10.1021/ja067139f. [DOI] [PubMed] [Google Scholar]; d MacKay JA, Landis ZC, Motika SE, Kench MH. J. Org. Chem. 2012;77:7768. doi: 10.1021/jo3015769. [DOI] [PubMed] [Google Scholar]
  • 4.a Xu Z, Lu X. Tetrahedron Lett. 1997;38:3461. [Google Scholar]; b Xu Z, Lu X. J. Org. Chem. 1998;63:5031. [Google Scholar]; c Xu Z, Lu X. Tetrahedron Lett. 1999;40:549. [Google Scholar]; d Zhu X-F, Lan J, Kwon O. J. Am. Chem. Soc. 2003;125:4716. doi: 10.1021/ja0344009. [DOI] [PubMed] [Google Scholar]; e Zhu X-F, Henry CE, Kwon O. Tetrahedron. 2005;61:6276. [Google Scholar]; f Wurz RP, Fu GC. J. Am. Chem. Soc. 2005;127:12234. doi: 10.1021/ja053277d. [DOI] [PubMed] [Google Scholar]; g Zhu X-F, Henry CE, Wang J, Dudding T, Kwon O. Org. Lett. 2005;7:1387. doi: 10.1021/ol050203y. [DOI] [PubMed] [Google Scholar]; h Zhu X-F, Schaffner A-P, Li RC, Kwon O. Org. Lett. 2005;7:2977. doi: 10.1021/ol050946j. [DOI] [PubMed] [Google Scholar]; i Jean L, Marinetti A. Tetrahedron Lett. 2006;47:2141. [Google Scholar]; j Meng X, Huang Y, Chen R. Org. Lett. 2009;11:137. doi: 10.1021/ol802453c. [DOI] [PubMed] [Google Scholar]; k Meng X, Huang Y, Zhao H, Xie P, Ma J, Chen R. Org. Lett. 2009;11:991. doi: 10.1021/ol802917d. [DOI] [PubMed] [Google Scholar]; l Wang T, Ye S. Org. Lett. 2010;12:4168. doi: 10.1021/ol101762z. [DOI] [PubMed] [Google Scholar]; m Na R, Jing C, Xu Q, Jiang H, Wu X, Shi J, Zhong J, Wang M, Benitez D, Tkatchouk E, Goddard WA, III, Guo H, Kwon O. J. Am. Chem. Soc. 2011;133:13337. doi: 10.1021/ja200231v. [DOI] [PMC free article] [PubMed] [Google Scholar]; n Hu J, Dong W, Wu X-Y, Tong X. Org. Lett. 2012;14:5530. doi: 10.1021/ol302634p. [DOI] [PubMed] [Google Scholar]; o Xie P, Lai W, Geng Z, Huang Y, Chen R. Chem. - Asian J. 2012;7:1533. doi: 10.1002/asia.201200140. [DOI] [PubMed] [Google Scholar]
  • 5.a Zheng S, Lu X. Org. Lett. 2008;10:4481. doi: 10.1021/ol801661y. [DOI] [PubMed] [Google Scholar]; b Zheng S, Lu X. Org. Lett. 2009;11:3978. doi: 10.1021/ol901618h. [DOI] [PubMed] [Google Scholar]; c Xie P, Huang Y, Chen R. Org. Lett. 2010;12:3768. doi: 10.1021/ol101611v. [DOI] [PubMed] [Google Scholar]; d Tian J, Zhou R, Sun H, Song H, He Z. J. Org. Chem. 2011;76:2374. doi: 10.1021/jo200164v. [DOI] [PubMed] [Google Scholar]
  • 6.a Winterfeldt E, Dillinger H-J. Chem. Ber. 1966;99:1558. [Google Scholar]; b Nozaki K, Sato N, Ikeda K, Takaya H. J. Org. Chem. 1996;61:4516. doi: 10.1021/jo951828k. [DOI] [PubMed] [Google Scholar]; c Nair V, Nair JS, Vinod AU, Rath NP. J. Chem. Soc., Perkin Trans. 1997;1:3129. [Google Scholar]; d Nair V, Nair JS, Vinod AU. Synthesis. 2000;2000:1713. [Google Scholar]; e Meng L-G, Cai P, Guo Q, Xue S. J. Org. Chem. 2008;73:8491. doi: 10.1021/jo801687v. [DOI] [PubMed] [Google Scholar]; f Hu J, Wei Y, Tong X. Org. Lett. 2011;13:3068. doi: 10.1021/ol200940a. [DOI] [PubMed] [Google Scholar]; g Nasiri F, Bayzidi M, Zolali A. Mol. Diversity. 2012;16:619. doi: 10.1007/s11030-012-9389-7. [DOI] [PubMed] [Google Scholar]; h Xie P, Li E, Zheng J, Li X, Huang Y, Chen R. Adv. Synth. Catal. 2013;355:161. [Google Scholar]; i Zhou Q, Chu X, Ge F, Cheng L, Lu T. Mol. Diversity. 2013;17:563. doi: 10.1007/s11030-013-9456-8. [DOI] [PubMed] [Google Scholar]; j Zhou Q-F, Chu X-P, Ge F-F, Wang Y, Lu T. Adv. Synth. Catal. 2013;355:2787. [Google Scholar]
  • 7.a Trost BM, Li C-J. J. Am. Chem. Soc. 1994;116:10819. [Google Scholar]; b Lu C, Lu X. Org. Lett. 2002;4:4677. doi: 10.1021/ol0270733. [DOI] [PubMed] [Google Scholar]; c Liu B, Davis R, Joshi B, Reynolds DW. J. Org. Chem. 2002;67:4595. doi: 10.1021/jo016154u. [DOI] [PubMed] [Google Scholar]; d Sriramurthy V, Barcan GA, Kwon O. J. Am. Chem. Soc. 2007;129:12928. doi: 10.1021/ja073754n. [DOI] [PMC free article] [PubMed] [Google Scholar]; e Chung YK, Fu GC. Angew. Chem., Int. Ed. 2009;48:2225. doi: 10.1002/anie.200805377. [DOI] [PMC free article] [PubMed] [Google Scholar]; f Sriramurthy V, Kwon O. Org. Lett. 2010;12:1084. doi: 10.1021/ol100078w. [DOI] [PMC free article] [PubMed] [Google Scholar]; g Szeto J, Sriramurthy V, Kwon O. Org. Lett. 2011;13:5420. doi: 10.1021/ol201730q. [DOI] [PMC free article] [PubMed] [Google Scholar]; h Zhou R, Wang J, Duan C, He Z. Org. Lett. 2012;14:6134. doi: 10.1021/ol302696e. [DOI] [PubMed] [Google Scholar]; i Lundgren RJ, Wilsily A, Marion N, Ma C, Chung YK, Fu GC. Angew. Chem. 2013;125:2585. doi: 10.1002/anie.201208957. [DOI] [PMC free article] [PubMed] [Google Scholar]; j Andrews IP, Blank BR, Kwon O. Chem. Commun. 2012;48:5373. doi: 10.1039/c2cc31347b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.a Boyce GR, Liu S, Johnson JS. Org. Lett. 2012;14:652. doi: 10.1021/ol2033527. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Henry CE, Kwon O. Org. Lett. 2007;9:3069. doi: 10.1021/ol071181d. [DOI] [PubMed] [Google Scholar]
  • 9.a Stubbs KA, Zhang N, Vocadlo DJ. Org. Biomol. Chem. 2006;4:839. doi: 10.1039/b516273d. [DOI] [PubMed] [Google Scholar]; b Goddard-Borger ED, Stubbs KA. J. Org. Chem. 2010;75:3931. doi: 10.1021/jo100614b. [DOI] [PubMed] [Google Scholar]
  • 10.a Denmark SE, Dappen IMS, Cramer CJ. J. Am. Chem. Soc. 1986;108:1306. [Google Scholar]; b Denmark SE, Hurd AR. J. Org. Chem. 2000;65:2875. doi: 10.1021/jo991680v. [DOI] [PubMed] [Google Scholar]; c Smirnov VO, Khomutova YA, Ioffe SL. Mendeleev Commun. 2008;18:255. [Google Scholar]
  • 11.Tiecco M, Testaferri L, Tingoli M, Marini F. J. Chem. Soc., Chem. Commun. 1994:221. [Google Scholar]
  • 12.a Barange DK, Raju BR, Kavala V, Kuo C-W, Tu Y-C, Yao C-F. Tetrahedron. 2010;66:3754. [Google Scholar]; b Wu M-Y, Li K, He T, Feng X-W, Wang N, Wang X-Y, Yu X-Q. Tetrahedron. 2011;67:2681. [Google Scholar]
  • 13.For examples of Michael additions of carbethoxymethylenetriphenylphosphorane to nitroalkenes, see: Asunskis J, Schechter H. J. Org. Chem. 1968;33:1164. Connor DT, von Strandtmann M. J. Org. Chem. 1973;38:1047. doi: 10.1021/jo00443a006..
  • 14. CCDC 1004071 contains the supplementary crystallographic data for compound 2m. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SI

RESOURCES